MapLight Therapeutics (MPLT) Capital Expenditures (2024 - 2025)
MapLight Therapeutics (MPLT) posted Capital Expenditures of $376000.0 for Q4 2025, up 254.72% sequentially from $106000.0 in Q4 2024, and up 254.72% YoY from $106000.0 in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Capital Expenditures (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Capital Expenditures for 2 years, with the latest figure at $376000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | MapLight Therapeutics | 642.40 Mn | 642.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Dec 31, 2024 | 106,000.00 |